1. Home
  2. RL vs ILMN Comparison

RL vs ILMN Comparison

Compare RL & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ralph Lauren Corporation

RL

Ralph Lauren Corporation

HOLD

Current Price

$366.87

Market Cap

22.1B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$128.82

Market Cap

18.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RL
ILMN
Founded
1967
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.1B
18.9B
IPO Year
1997
2000

Fundamental Metrics

Financial Performance
Metric
RL
ILMN
Price
$366.87
$128.82
Analyst Decision
Strong Buy
Hold
Analyst Count
14
15
Target Price
$360.29
$114.93
AVG Volume (30 Days)
617.9K
1.5M
Earning Date
11-06-2025
10-30-2025
Dividend Yield
0.99%
N/A
EPS Growth
28.75
N/A
EPS
13.54
4.46
Revenue
$7,570,600,000.00
$4,288,000,000.00
Revenue This Year
$12.88
N/A
Revenue Next Year
$4.97
$2.08
P/E Ratio
$27.22
$28.91
Revenue Growth
12.32
N/A
52 Week Low
$176.61
$68.70
52 Week High
$374.00
$153.06

Technical Indicators

Market Signals
Indicator
RL
ILMN
Relative Strength Index (RSI) 65.98 66.70
Support Level $349.40 $124.27
Resistance Level $374.00 $129.72
Average True Range (ATR) 10.51 3.90
MACD 1.58 -0.41
Stochastic Oscillator 89.52 77.82

Price Performance

Historical Comparison
RL
ILMN

About RL Ralph Lauren Corporation

Founded by designer Ralph Lauren (current executive chairman and chief creative officer) in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: